Quick Answer
Guardant Health, Inc. reported Operating Income Loss of -$437.25 million for the year ending 2025.
- Guardant Health, Inc. showed an increase of +1.4% in Operating Income Loss from 2024 to 2025.
- This data is from Guardant Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: -$28.68 million | Q1 2018: -$18.65 million | Q2 2018: -$22.70 million | Q3 2018: -$24.21 million | Q1 2019: -$23.66 million | Q2 2019: -$15.27 million | Q3 2019: -$17.48 million | Q1 2020: -$34.91 million | Q2 2020: -$54.62 million | Q3 2020: -$74.25 million | Q1 2021: -$107.86 million | Q2 2021: -$97.64 million | Q3 2021: -$107.29 million | Q1 2022: -$123.34 million | Q2 2022: -$130.32 million | Q3 2022: -$144.60 million | Q1 2023: -$134.06 million | Q2 2023: -$119.62 million | Q3 2023: -$113.54 million | Q1 2024: -$99.68 million | Q2 2024: -$100.62 million | Q3 2024: -$117.33 million | Q1 2025: -$111.04 million | Q2 2025: -$106.41 million | Q3 2025: -$98.99 million.
- Over the full 10 years of available data (2016 to 2025), Guardant Health, Inc.'s Operating Income Loss has declined by 897.2%.
- Historical annual values: Fiscal year 2025: -$437.25 million | Fiscal year 2024: -$443.59 million | Fiscal year 2023: -$564.73 million | Fiscal year 2022: -$544.38 million | Fiscal year 2021: -$411.00 million | Fiscal year 2020: -$254.95 million | Fiscal year 2019: -$82.37 million | Fiscal year 2018: -$92.94 million | Fiscal year 2017: -$76.61 million | Fiscal year 2016: -$43.85 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: